Skip common site navigation and headers
United States Environmental Protection Agency
Endocrine Disruptor Research Initiative
Contact Us | Print Version Search: NCER Advanced Search
Begin Hierarchical Links EPA Home > Table2.NCI >  70536-01 Phytoestrogens and Breast Cancer–A Pilot Study End Hierarchical Links End Hierarchical Links

 

EDRI Federal Project Inventory:
70536-01 Phytoestrogens and Breast Cancer–A Pilot Study



  1. Sponsor Organization: NIH/NCI

  2. Project Title: 70536-01 PHYTOESTROGENS AND BREAST CANCER--A PILOT STUDY

  3. Project Focus: EXPOSURE ASSESSMENT

  4. Description: Phytoestrogens (isoflavonoids and lignans) have anti-estrogenic and tumor growth inhibition properties. The long-term objective of this research is to assess whether these compounds protect against breast cancer. The specific aim ofthis study is to assess the long-term reliability of serum measurements of phytoestrogens in order to adequately plan anepidemiologic study in which serum samples from participants in an ongoing case-control study of breast cancer will beassayed for phytoestrogens. The case-control study is nested within a prospective cohort, the New York University(NYU) Women's Health Study, and serum samples were collected prior to diagnosis and frozen for future biochemicalanalyses. For a subset of the cohort, repeated serum samples were collected at approximately yearly intervals. Dataon the reliability of serum measurements of phytoestrogens is needed to select the optimum design with respect tosample size and number of samples/participants in the projected epidemiologic study. The optimum design will be theone which minimizes the error in measurement bias (systematic underestimation) commonly observed in studies of theassociation of serum nutrients with disease risk. The reliability coefficients will also be used in the analysis of the case-control study to correct relative risk estimates for residual exposure error measurement. The study will use the sameresource that will be used in the epidemiologic study of the association of phytoestrogens with breast cancer, i.e. theNYU Women's Health Study bank of frozen serum samples. The samples were collected between 1985 and 1991 from14,291 healthy women who have been actively followed-up for breast and other cancers ever since. For a subset of the participants (approximately 25 percent), three or more repeated serum samples (up to 8), collected at approximatelyyearly intervals, are available. Thirty-two women (16 pre- and 16 post-menopausal at blood donation) will beselected at random among participants who contributed at least three blood donations and who are not included in any ofthe currently ongoing case-control studies nested within this cohort. For each of these women, three serum samples willbe retrieved from the serum bank and assayed for four phytoestrogens: enterolactone and enterodiol, the two mainhuman lignans, and daidzein and genistein, the two main human isoflavonoids. The corresponding reliabilitycoefficients will be calculated. The study will also assess whether factors such as age, menopausal status and frozenstorage time affect serum levels of phytoestrogens. Between and within laboratory batch variability will also beestimated.

  5. References:

  6. Category: METHODS

  7. Subcategory: EXPOSURE AND RISK MODELS

  8. Keywords for Experimental System/Species: HUMAN

  9. Keywords for Experimental Endpoints: EXPOSURE MONITORING, EPIDEMIOLOGY

  10. Chemical Agents: PHYTOESTROGENS

  11. Performing Institution: NEW YORK UNIVERSITY

  12. Contact: CONTRACT PERSON: ELAINE C. LEE; BUILDING 31; 11A21; NATIONAL CANCER INSTITUTE, NIH,BETHESDA, MD 20892-2590; 301-496-5515; LEEE@OD.NCI.NIH.GOV


 

 
Begin Site Footer